pharma deals

Deal value increased by 320 per cent in September 2025, compared to September 2024

Read more

Pfizer enters into an exclusive licensing agreement with 3SBio

Read more

Deal value drops by 34.2 per cent in April 2025, compared to April 2024

Read more

Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset

Read more

Deal value declined by 86.4 per cent in Dec 2024, compared to Dec 2023

Read more

Funding in pharma surges in December 2024, reached $69.8 mn

Read more

Lupin acquires Huminsulin from Eli Lilly

Read more

Power Gummies raises ₹10 cr, aims to expand product range

Read more

M&A in pharma sees deals worth $14.8 bn in Nov 2024

Read more

Merck Life Science in India, GeNext Genomics sign MoU

Read more